These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 626922)

  • 1. Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease?
    Poleksic S; Yeung KY
    Cancer; 1978 Jan; 41(1):12-6. PubMed ID: 626922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Second tumor following Hodgkin's disease].
    Schmitt K; Tulzer W
    Padiatr Padol; 1984; 19(3):259-62. PubMed ID: 6548008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy in the treatment of Hodgkin's disease.
    Canellos GP; Come SE; Skarin AT
    Semin Hematol; 1983 Jan; 20(1):1-24. PubMed ID: 6189191
    [No Abstract]   [Full Text] [Related]  

  • 5. Second malignancy complicating Hodgkin's disease.
    Tawil E; Mercier JP
    J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
    Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
    Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
    Matusewicz W; Drzewoski J; Robak T; Krykowski E
    Kardiol Pol; 1983; 26(7):591-4. PubMed ID: 6689036
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
    Cunningham J; Mauch P; Rosenthal DS; Canellos GP
    Cancer Treat Rep; 1982 Apr; 66(4):1015-22. PubMed ID: 7074629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
    Swerdlow AJ; Schoemaker MJ; Allerton R; Horwich A; Barber JA; Cunningham D; Lister TA; Rohatiner AZ; Vaughan Hudson G; Williams MV; Linch DC
    J Clin Oncol; 2001 Mar; 19(6):1610-8. PubMed ID: 11250989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
    Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
    J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary toxicity secondary to procarbazine.
    Mahmood T; Mudad R
    Am J Clin Oncol; 2002 Apr; 25(2):187-8. PubMed ID: 11943900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
    da Cunha MF; Meistrich ML; Fuller LM; Cundiff JH; Hagemeister FB; Velasquez WS; McLaughlin P; Riggs SA; Cabanillas FF; Salvador PG
    J Clin Oncol; 1984 Jun; 2(6):571-7. PubMed ID: 6547167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhagic cystitis with MOPP therapy.
    Royal JE; Seeler RA
    Cancer; 1978 Apr; 41(4):1261-4. PubMed ID: 638990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of sternum and rib in a patient treated for Hodgkin's disease.
    Blijham GH; Vermeulen A; Mendes de Leon DE
    Cancer; 1985 Nov; 56(9):2292-4. PubMed ID: 3840407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.
    Jacquillat C; Khayat D; Desprez-Curely JP; Weil M; Brocheriou C; Auclerc G; Chamseddine N; Bernard J
    Cancer; 1984 Feb; 53(3):459-62. PubMed ID: 6362816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recently recognized complications of cancer chemotherapy.
    Arseneau JC; Canellos GP; DeVita VT; Sherins RJ
    Ann N Y Acad Sci; 1974; 230():481-8. PubMed ID: 4595953
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute leukemias and solid tumors in the course of Hodgkin disease].
    Jacquillat C; Auclerc G; Weil M; Auclerc MF; Maral J
    Bull Cancer; 1983; 70(1):61-6. PubMed ID: 6687694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant myelosclerosis (acute myelofibrosis): report of two cases following cytotoxic chemotherapy.
    Ali NO; Janes WO
    Cancer; 1979 Apr; 43(4):1211-5. PubMed ID: 445324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty years of MOPP therapy for Hodgkin's disease.
    Longo DL; Young RC; Wesley M; Hubbard SM; Duffey PL; Jaffe ES; DeVita VT
    J Clin Oncol; 1986 Sep; 4(9):1295-306. PubMed ID: 3528400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.